The association between testosterone deficiency and type 2 diabetes will be covered during an online event for healthcare professionals later this week.
Entitled ‘40% of men with type 2 diabetes have symptomatic testosterone deficiency – why are we still not finding and treating these men?’, the virtual meeting will take place on Thursday, May 5, between 5pm and 6pm.
The webinar, which is being held by the Association of British Clinical Diabetologists (ABCD) and accredited by the Royal College of Physicians, has lined up a series of diabetes and endocrinology experts who will discuss a range of subjects, including testosterone replacements and the connection between testosterone deficiency and type 2 diabetes mortality rates.
In addition, the speakers will discuss the benefits of the ABCD nationwide audit programme and help clinicians to identify men with both type 2 diabetes and symptomatic testosterone deficiency.
According to the ABCD, testosterone replacement has been shown to improve insulin resistance, lower HbA1c and cholesterol levels and reduce body weight and mortality.
The speakers for this webinar include Professor Hugh Jones, Consultant Endocrinologist at the Royal Hallamshire Hospital and Dr Bob Ryder, Consultant Diabetologist at City Hospital, Birmingham.
Dr Dinesh Nagi, Honorary Consultant in Diabetes and Endocrinology at Pinderfields Hospital Wakefield, will be chairing the online event.
Registered delegates will also have the opportunity to ask questions to the speakers at the end of the sessions.
A certification of attendance will also be issued to those joining the webinar live.
To register for the virtual event, click here.
Photo by: jarun011